"C" Trouble: Class IC Anti-arrhythmic Toxicity
<p>The most common cardiac arrhythmia encountered in clinical practice is atrial fibrillation (AFib). AFib has significant effects on long-term mortality and stroke, and contributes greatly to overall healthcare costs, affects quality of life and the functional status of many patients [1]. The...
Gardado en:
Main Authors: | Maia Eng# (Author), William Wung# (Author), Uma N Srivatsa# (Author), Gagan D Singh (Author) |
---|---|
Formato: | Libro |
Publicado: |
Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,
2017-06-30.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Lidocaine as an anti‐arrhythmic drug: Are there any indications left?
por: Sati Güler, et al.
Publicado: (2023) -
Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
por: Yuling Jing, et al.
Publicado: (2022) -
Comprehensive in vitro pro‐arrhythmic assays demonstrate that omecamtiv mecarbil has low pro‐arrhythmic risk
por: Yusheng Qu, et al.
Publicado: (2021) -
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
por: Ping Zhu, et al.
Publicado: (2023) -
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
por: James A. Coleman, et al.
Publicado: (2024)